GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai MicroPort MedBot (Group) Co Ltd (HKSE:02252) » Definitions » Short-Term Debt & Capital Lease Obligation

Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Short-Term Debt & Capital Lease Obligation : HK$298.7 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai MicroPort MedBot (Group) Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Shanghai MicroPort MedBot (Group) Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$298.7 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Shanghai MicroPort MedBot (Group) Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$439.4 Mil.


Shanghai MicroPort MedBot (Group) Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Shanghai MicroPort MedBot (Group) Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai MicroPort MedBot (Group) Co Short-Term Debt & Capital Lease Obligation Chart

Shanghai MicroPort MedBot (Group) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial 8.64 64.73 65.01 462.93 298.66

Shanghai MicroPort MedBot (Group) Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 65.01 440.81 462.93 261.30 298.66

Shanghai MicroPort MedBot (Group) Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Shanghai MicroPort MedBot (Group) Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shanghai MicroPort MedBot (Group) Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai MicroPort MedBot (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
1601 Zhangdong Road, Room 101, Area B, Building 1, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. Its business covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives key revenue from the People's Republic of China, followed by Europe, Africa, Australia, and other regions.
Executives
He Chao 2201 Interest of corporation controlled by you
Ji Shufang 2202 Interest of your spouse
Shang Hai Qing Zhen Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo 2103 Interests held jointly with another person
Wei Chuang Yi Liao Ke Xue You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Qing Min Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo 2101 Beneficial owner
Wei Chuang Tou Zi Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Yuan Shuai 2201 Interest of corporation controlled by you
Wu Kaili 2202 Interest of your spouse
Shenzhen Gao Ling Tiancheng Phase Iii Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shenzhen Gao Ling Muqi Equity Investment Fund Llp 2201 Interest of corporation controlled by you
Xiamen Gao Ling Ruiqi Equity Investment Fund Llp 2201 Interest of corporation controlled by you
Zhuhai Gao Ling Chongheng Equity Investment Llp 2101 Beneficial owner
Shang Hai Wei Chuang Tou Zi Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Mo Hua Ren Gong Zhi Neng Ke Ji You Xian Gong Si 2103 Interests held jointly with another person

Shanghai MicroPort MedBot (Group) Co Headlines

No Headlines